Ruling: HIV victim exempted from disclosing condition to partner

The Wellington District Court, New Zealand, has ruled that HIV-positive people don't have to disclose their condition to their sexual partners if condoms are used. Justin Dalley was charged with criminal // nuisance after not disclosing to his female partner his HIV positive status before the...

Valeant Pharmaceuticals Reports Second Quarter Financial Results

...n making, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors with a...king, forecasting future results and evaluating current performance. By disclosing non-GAAP financial measures, management intends to provide investors wi...

West Announces Second Quarter 2009 Results

...oals for determining payouts under annual and long-term incentive programs. We believe that investors' understanding of our performance is enhanced by disclosing these measures. The items excluded from adjusted operating profit and adjusted diluted EPS are: Restructuring Charges: During the sec...

ViroPharma Incorporated Reports Second Quarter 2009 Financial Results

... manage the business. Accordingly, management believes investors' understanding of the Company's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP adjusted net income should not be viewed in isolation, or as a substitute for or superior to reported or G...

Kansas City Patients Rate Their Doctors in Most Reliable Survey of Its Kind

...employers, insurers, health groups, activists and others to work toward common, fundamental objectives leading to better care, including measuring and disclosing doctors' and hospitals' performance and educating consumers about chronic diseases. "Patients are increasingly being asked to take on more an...

Tijuana Newspaper, Zeta Tijuana, Releases Detailed List of Day Care Center Owners and Their Total Earnings; Interchildren, Inc. Calls for Newspaper Boycott

...d development group, and a childcare center owner on both sides of the border in San Diego. "While much of the information is available to the public, disclosing income totals along with names turns these good families into immediate targets for kidnappers in the underworld." In a report published by Z...

4 out of 5 CA Voters Demand Health Insurer "Code of Conduct"

...rofits. It would create clinical autonomy, allowing physicians to make decisions based on patient needs without artificial barriers; transparency; the disclosing of information regarding health plan benefits and policies that will help facilitate patient decisions; corporate integrity and patient safety and wel...

UT School of Public Health researchers develop game for HIV+ youth

...raception, and also watch video clips from experts and peers who are also HIV+. +CLICK is designed to target four behaviors: choosing not to have sex; disclosing HIV status to a potential partner; using condoms correctly and consistently; and using an effective method of birth control along with condoms. Par...

Report: Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Preventing Honest Disclosures

...bilities. CONCEALED SCIENCE . Concealing emerging science that forewarns of potential liabilities in the future. THE KNOWN MINIMUM . disclosing only the "known minimum" of potential liabilities, even though a more realistic assessment might be so much larger that it would indicate the potentia...

Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)

...tes by combining the benefit of our Hemopurifier(R) with the interferon-ribavirin standard of care (SOC) administered to HCV-infected patients. Since disclosing our strategy, a candidate business partner has introduced us to clinical data that validates the mechanical removal of HCV through blood filtration in...

disclosing in Medical Technology

Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009

...on & Johnson today announced its support for the Physician Payments Sunshine Act of 2009 (S. 301). The company also committed to begin voluntarily disclosing payments made to physicians by its U.S. pharmaceutical, medical device and diagnostics companies. "We are in favor of greater transparency regard...

Amicus Therapeutics Announces Second Quarter 2008 Financial Results

...year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for re...

GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update

...cination increased the frequency and magnitude of the CD8 T-cell and Antibody responses -- In November, GeoVax filed a Form 8-K with the SEC disclosing that it was unlikely to receive the full amount of its previously announced $7.5 million equity placement with Pure Capital LLC ("Pure"). The...

Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule

...storical facts are forward-looking statements. These forward-looking statements include statements regarding: the timing for completing enrollment and disclosing results from Cadence's clinical trials of IV acetaminophen; the potential for submitting an NDA for IV acetaminophen and the timing for any such submi...

Senate Passes Drug-Safety Reforms to Prevent Future Vioxx-type Disasters; House Urged to Act on Strong Drug Safety Bill

...d with a much weaker measure that only allows the FDA to fine companies ($150,000 per violation) for ads that are false or misleading when it comes to disclosing a "serious health risk." With new drugs, serious health risks often aren't clear until a drug has been on the market for years and used by millions, w...

disclosing in Biological News

Human adult testes cells can become embryonic-like

... has provided enough valuable tissue to allow them to make their discoveries. While they have published their preliminary results before, they are now disclosing a new and simpler method to isolate the testes stem/progenitor cells than has not been seen in other published procedures in humans and rodents. Be...

Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008

... the company's management to evaluate operational results. The company believes this information may be useful to investors. In addition to disclosing financial results calculated in accordance with U.S. generally accepted accounting principles (GAAP), the company's earnings release contains ...

Need for federal protection against genetic discrimination

...d from requiring individuals and families to undergo genetic testing Position 5: Insurers and employers should be prohibited from collecting and/or disclosing an individual or familys genetic information. Written and informed consent should be required for each disclosure of genetic information and should in...

Study finds health professionals, public unprepared for genomic medicine

...searchers. The study outlines several promising electronic tools that may offer benefits, including genetic consultation done via videoconference, disclosing genetic test results via telephone, and imbedding clinical support tools for physicians in electronic health records. Researchers also found that ...

World's largest investor coalition seeks further disclosure on climate change and shareholder value

...nas 100 largest companies, by market capitalisation. This is a key step in leveraging investor influence to support Chinese companies in measuring and disclosing their carbon emissions and climate related strategy. CDP is working with local agent SynTao to encourage Chinese enterprises to engage with these issu...

Knowledge of infection may prevent spread of herpes virus

...k, and Leone suggest that physicians should not only increase testing for HSV, but should also counsel their patients about transmitting the virus and disclosing their HSV status to sex partners. ...

The biggest family tree ever

...ct. Participants can obtain their personal results on a Web site. Participants who want to find out about a whole new set of relatives can do so by disclosing their names to Family Tree DNA and then plan their biggest family reunion ever. Websites: The Genographic Project Michael F. Hammer Arizona...

disclosing in Biological Technology

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...with the U.S. Securities and Exchange Commission (the "SEC") a Schedule 13D disclosing their beneficial ownership of the Company's Class A Common Stock and a Schedule 13D disclosing their beneficial ownership of the Company's Class B Common Stock. Such Rep...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for re...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... Non-GAAP Financial Measures Mylan is disclosing non-GAAP financial measures when providing financi...erally accepted in the U.S. (GAAP). In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing non-GAAP results that exclude items such as amorti...

Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

...secured notes issued in April 2009 (the "Pre-Petition Lenders"), and (c) the agent for the DIP Lenders. The Company filed a Form 8-K on June 19, 2009 disclosing the material terms of the Restructuring Agreement. The restructuring plan is subject to the submission and approval of a plan of reorganization for t...

Medarex Announces 2009 First Quarter Financial Results

...ng the items discussed below. Medarex's management believes investors' understanding of Medarex's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP net loss and non-GAAP net loss per share should not be viewed in isolation or as a substitute for GAAP net...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

...ct how we manage the business. Accordingly, we believe investors' understanding of the Company's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP adjusted net income should not be viewed in isolation, or as a substitute for or superior to reported or G...

Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs

...y of our compound and be able to profit from sales of Oxycyte to licensees," said Chris J. Stern, company chairman and CEO. The companies are not disclosing the financial terms of the supply agreement. About Oxygen Biotherapeutics, Inc. Oxygen Biotherapeutics, Inc. is dedicated to commercializing i...

Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results

...nesis filed today a Form 12b-25 with the Securities and Exchange Commission disclosing its inability to timely file its Annual Report on Form 10-K for the year en...ty of the company to continue as a going concern make a public announcement disclosing the receipt of such opinion. With the anticipated proceeds from the initial...

AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results

...vel, we completed the recruitment of over 1,600 patients for our Phase 3 program in BPH with cetrorelix, according to schedule. We now look forward to disclosing results of this program throughout the second half of 2009. We also made significant progress with our lead oncology compound, AEZS-108, in endometria...

Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008

... Non-GAAP Financial Measures Mylan is disclosing non-GAAP financial measures when providing financi...cepted in the United States (GAAP). In addition to disclosing its financial results determined in accordance with GAAP, Mylan is disclosing non-GAAP results that exclude items such as amorti...